Does PERISCOPE II mark the end of cytoreductive surgery and HIPEC for gastric cancer with peritoneal metastases?. // Surgical Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0960740426002689?dgcid=rss_sd_all
Does PERISCOPE II mark the end of cytoreductive surgery and HIPEC for gastric cancer with peritoneal metastases?. Surgical Oncology. https://www.sciencedirect.com/science/article/pii/S0960740426002689?dgcid=rss_sd_all
“Does PERISCOPE II mark the end of cytoreductive surgery and HIPEC for gastric cancer with peritoneal metastases?.” Surgical Oncology.
@article{article95273,
title = {Does PERISCOPE II mark the end of cytoreductive surgery and HIPEC for gastric cancer with peritoneal metastases?},
journal = {Surgical Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0960740426002689?dgcid=rss_sd_all}
}
ABSTRACT Objectives The aim of this study was to determine whether certain cephalometric findings can predict the future need for orthognathic surgery (OS) in cleft lip (CL), cleft palate (CP), unilateral cleft lip and palate (UCLP),...